Ads
related to: johns hopkins prostate cancer center- Find An Imaging Site
Locate the nearest imaging site
or contact customer service.
- Talk To Your Doctor
Review questions to start a
conversation with your doctor.
- About Us
Understand how a PSMA PET scan may
help with your treatment plan.
- Reimbursement Support
The patient support program
can assist insurance assessment.
- Find An Imaging Site
Search results
Results from the WOW.Com Content Network
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University is an NCI-Designated Comprehensive Cancer Center in Baltimore, MD. It was established in 1973 and received its NCI designation that same year as one of the first designated cancer centers in the country. [1] [2]
William G. Nelson is the Marion I. Knott Professor of Oncology, Urology, Pharmacology, Pathology, and Medicine at the Johns Hopkins School of Medicine.He earned his B.A. in Chemistry from Yale University in 1980 and his M.D. and Ph.D. in Pharmacology from Johns Hopkins School of Medicine in 1987.
Patrick C. Walsh is an American urologist, researcher and writer, best known for developing "the anatomic approach to radical prostatectomy", involving nerve-sparing techniques which reduced the likelihood of impotence and urinary incontinence.
Platz also co-led a 10-year study of more than 30,000 health professionals that found the longer men take cholesterol-lowering drugs, the far less likely they were to develop advanced prostate cancer. [4] In 2008, Platz was appointed co-director of the Cancer Prevention and Control Program at the Sidney Kimmel Comprehensive Cancer Center. [5]
Theodore L. DeWeese, M.D., is the Francis Watt Baker, M.D. and Lennox D. Baker, M.D. dean of the medical faculty at Johns Hopkins University School of Medicine and the chief executive officer of Johns Hopkins Medicine. [1] He was appointed in December 2023 after serving in an interim capacity for 18 months. [2]
Simons’ laboratories, partly funded by the Prostate Cancer Foundation, at Johns Hopkins University and Emory University made original contributions to understanding the molecular biology of prostate cancer metastasis [5] [6] and principles of “broken immune tolerance” via T cell based immunotherapy for prostate cancer.
Ads
related to: johns hopkins prostate cancer center